Quercetin antagonism of Bay K 8644 effects on rat tail artery L-type Ca2+ channels

European Journal of Pharmacology

Volumn 598, Issue 1-3, 2008, Pages 75-80

  Saponara, Simona ^a   Sgaragli, Giampietro ^a   Fusi, Fabio ^a  

^a UNIVERSITY OF SIENA   (Italy)

Author keywords

Bay K 8644; Quercetin; Rat tail artery myocyte; Whole cell patch clamp

Indexed keywords

1,4 DIHYDRO 2,6 DIMETHYL 5 NITRO 4 [2 (TRIFLUOROMETHYL)PHENYL] 3 PYRIDINECARBOXYLIC ACID METHYL ESTER; CALCIUM CHANNEL L TYPE; QUERCETIN;

ANIMAL CELL; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG EFFECT; DRUG POTENCY; HEART PROTECTION; MALE; MUSCLE CELL; NONHUMAN; PATCH CLAMP; PRIORITY JOURNAL; RAT; SPRAGUE DAWLEY RAT; TAIL ARTERY;

3-PYRIDINECARBOXYLIC ACID, 1,4-DIHYDRO-2,6-DIMETHYL-5-NITRO-4-(2-(TRIFLUOROMETHYL)PHENYL)-, METHYL ESTER; ANIMALS; ANTIOXIDANTS; ARTERIES; CALCIUM CHANNEL AGONISTS; CALCIUM CHANNELS, L-TYPE; DATA INTERPRETATION, STATISTICAL; KINETICS; MUSCLE, SMOOTH, VASCULAR; MYOCYTES, SMOOTH MUSCLE; PATCH-CLAMP TECHNIQUES; POTASSIUM CHANNEL BLOCKERS; QUERCETIN; RATS; TETRAETHYLAMMONIUM;

EID: 54049100675     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2008.08.016     Document Type: Article

References (36)

1. Arts I.C., and Hollman P.C. Polyphenols and disease risk in epidemiologic studies. Am. J. Clin. Nutr. 81 (2005) 317S-325S
2. Bolton T.B., Aaronson P.I., and Mackenzie I. Voltage-dependent calcium channel in intestinal and vascular smooth muscle cells. Ann. N. Y. Acad. Sci. 522 (1988) 32-42
3. Duarte J., Perez-Vizcaino F., Zarzuelo A., Jimenez J., and Tamargo J. Vasodilator effects of quercetin in isolated rat vascular smooth muscle. Eur. J. Pharmacol. 239 (1993) 1-7
4. 2+ channel via superoxide anion generation. Br. J. Pharmacol. 133 (2001) 988-996
5. 2+ channels activation and contraction elicited by myricetin on vascular smooth muscles. Naunyn Schmiedeberg's Arch. Pharmacol. 368 (2003) 470-478
6. Fusi F., Saponara S., Pessina F., Gorelli B., and Sgaragli G.P. Effects of quercetin and rutin on vascular preparations. A comparison between mechanical and electrophysiological phenomena. Eur. J. Nutr. 42 (2003) 10-17
7. 2+ current. J. Pharmacol. Exp. Ther. 313 (2005) 790-797
8. Hamill O.P., Marty A., Neher E., Sakmann B., and Sigworth F.J. Improved patch-clamp techniques for high-resolution current recording from cells and cell-free membrane patches. Pflügers Arch. 391 (1981) 85-100
9. Hamilton S.L., and Perez M. Toxins that affect voltage-dependent calcium channels. Biochem. Pharmacol. 36 (1987) 3325-3329
10. Harwood M., Danielewska-Nikiel B., Borzelleca J.F., Flamm G.W., Williams G.M., and Lines T.C. A critical review of the data related to the safety of quercetin and lack of evidence of in vivo toxicity, including lack of genotoxic/carcinogenic properties. Food Chem. Toxicol. 45 (2007) 2179-2205
11. 2+ channel block and inactivation: common molecular determinants. Trends Pharmacol. Sci. 19 (1998) 439-443
12. Hess P., Lansman J.B., and Tsien R.W. Different modes of Ca channel gating behaviour favoured by dihydropyridine Ca agonists and antagonists. Nature 311 (1984) 538-544
13. Hille B. Selective permeability: independence. In: Ion Channels of Excitable Membranes. Sinauer Associates, Sunderland, Massachusetts (2001) 441-470
14. 2+ channels. Evidence for an agonistic action. J. Biol. Chem. 265 (1990) 1156-1166
15. Kokubun S., and Reuter H. Dihydropyridine derivatives prolong the open state of Ca channels in cultured cardiac cells. Proc. Natl. Acad. Sci. USA 81 (1984) 4824-4827
16. Manach C., Williamson G., Morand C., Scalbert A., and Remesy C. Bioavailability and bioefficacy of polyphenols in humans. I. Review of 97 bioavailability studies. Am. J. Clin. Nutr. 81 (2005) 230S-242S
17. Marks T.N., and Jones S.W. Calcium currents in the A7r5 smooth muscle-derived cell line. An allosteric model for calcium channel activation and dihydropyridine agonist action. J. Gen. Physiol. 99 (1992) 367-390
18. McDonald T.F., Pelzer S., Trautwein W., and Pelzer D.J. Regulation and modulation of calcium channels in cardiac, skeletal, and smooth muscle cells. Physiol. Rev. 74 (1994) 365-507
19. Patmore L., Duncan G.P., Clarke B., Anderson A.J., Greenhouse R., and Pfister J.R. RS 30026: a potent and effective calcium channel agonist. Br. J. Pharmacol. 99 (1990) 687-694
20. Petkov G.V., Fusi F., Saponara S., Gagov H., Sgaragli G.P., and Boev K.K. Characterization of voltage-gated calcium currents in freshly isolated smooth muscle cells from rat tail main artery. Acta Physiol. Scand. 173 (2001) 257-265
21. Rampe D., and Lacerda A.E. A new site for the activation of cardiac calcium channels defined by the nondihydropyridine FPL 64176. J. Pharmacol. Exp. Ther. 259 (1991) 982-987
22. 2+ concentrations. J. Gen. Physiol. 107 (1996) 459-472
23. Sanguinetti M.C., Krafte D.S., and Kass R.S. Voltage-dependent modulation of Ca channel current in heart cells by Bay K 8644. J. Gen. Physiol. 88 (1986) 369-392
24. 2+ channels in rat tail artery smooth muscle cells. Br. J. Pharmacol. 135 (2002) 1819-1827
25. Scalbert A., Manach C., Morand C., Remesy C., and Jimenez L. Dietary polyphenols and the prevention of diseases. Crit. Rev. Food Sci. Nutr. 45 (2005) 287-306
26. 2+ sensitivity of smooth muscle and nonmuscle myosin II: modulated by G proteins, kinases, and myosin phosphatase. Physiol. Rev. 83 (2003) 1325-1358
27. Stansfeld C., and Mathie A. Recording membrane currents of peripheral neurones in short-term culture. In: Wallis D.I. (Ed). Electrophysiology. A Practical Approach (1993), IRL Press, Oxford 3-28
28. Su C.M., Swamy V.C., and Triggle D.J. Calcium channel activation in vascular smooth muscle by BAY K 8644. Can. J. Physiol. Pharmacol. 62 (1984) 1401-1410
29. 1 cells. Eur. J. Pharmacol. 414 (2001) 125-133
30. Triggle D.J., and Rampe D. 1,4-Dihydropyridine activators and antagonists: structural and functional distinctions. Trends Pharmacol. Sci. 10 (1989) 507-511
31. Visentin S., Amiel P., Fruttero R., Boschi D., Roussel C., Giusta L., Carbone E., and Gasco A. Synthesis and voltage-clamp studies of methyl 1,4-dihydro-2,6-dimethyl-5-nitro-4-(benzofurazanyl)pyridine-3-carboxylate racemates and enantiomers and of their benzofuroxanyl analogues. J. Med. Chem. 42 (1999) 1422-1427
32. 2+ channel agonists. Mol. Pharmacol. 64 (2003) 235-248
33. Wang R., Karpinski E., and Pang P.K. Two types of calcium channels in isolated smooth muscle cells from rat tail artery. Am. J. Physiol. 256 (1989) H1361-H1368
34. Williamson G., and Manach C. Bioavailability and bioefficacy of polyphenols in humans. II. Review of 93 intervention studies. Am. J. Clin. Nutr. 81 (2005) 243S-255S
35. Wu S.N., Chiang H.T., Shen A.Y., and Lo Y.K. Differential effects of quercetin, a natural polyphenolic flavonoid, on L-type calcium current in pituitary tumor (GH3) cells and neuronal NG108-15 cells. J. Cell. Physiol. 195 (2003) 298-308
36. Zahradnikova A., Minarovic I., and Zahradnik I. Competitive and cooperative effects of Bay K 8644 on the L-type calcium channel current inhibition by calcium channel antagonists. J. Pharmacol. Exp. Ther. 322 (2007) 638-645